These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28166594)

  • 1. Influence of Dyslipidemia on the Quality of Sexual Life in Women in the Menacme using a Combined Oral Contraceptive.
    Strufaldi R; Pompei LM; Steiner ML; Fernandes CE
    Rev Bras Ginecol Obstet; 2016 Dec; 38(12):600-608. PubMed ID: 28166594
    [No Abstract]   [Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels.
    Strufaldi R; Pompei LM; Steiner ML; Cunha EP; Ferreira JA; Peixoto S; Fernandes CE
    Contraception; 2010 Aug; 82(2):147-54. PubMed ID: 20654755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a drospirenone-containing combined oral contraceptive on female sexual function: a prospective randomised study.
    Čiaplinskienė L; Žilaitienė B; Verkauskienė R; Žalinkevičius R; Bumbulienė Ž; Vanagienė V; Bitzer J
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):395-400. PubMed ID: 27535063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
    Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
    Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17β-Estradiol.
    Caruso S; Cianci S; Cariola M; Fava V; Di Pasqua S; Cianci A
    J Womens Health (Larchmt); 2017 Jul; 26(7):728-734. PubMed ID: 28323519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women.
    Baldassarre M; Alvisi S; Mancini I; Moscatiello S; Marchesini G; Seracchioli R; Meriggiola MC
    J Sex Med; 2016 Jan; 13(1):46-54. PubMed ID: 26755086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
    El-Haggar SM; Mostafa TM
    Endocrine; 2015 Aug; 49(3):820-7. PubMed ID: 25539793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact on sexual function of laparoscopic treatment and subsequent combined oral contraceptive therapy in women with deep infiltrating endometriosis?
    Mabrouk M; Montanari G; Di Donato N; Del Forno S; Frascà C; Geraci E; Ferrini G; Vicenzi C; Raimondo D; Villa G; Zukerman Z; Alvisi S; Seracchioli R
    J Sex Med; 2012 Mar; 9(3):770-8. PubMed ID: 22321207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.
    Ghani RA; Bin Yaakob I; Wahab NA; Zainudin S; Mustafa N; Sukor N; Wan Mohamud WN; Kadir KA; Kamaruddin NA
    J Clin Lipidol; 2013; 7(5):446-53. PubMed ID: 24079286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia and sexual function in premenopausal women.
    Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Cozzolino D; Saccomanno F; Giugliano D
    J Sex Med; 2009 Jun; 6(6):1696-1703. PubMed ID: 19453904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.